eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | cystoid macular dystrophy |
| Comorbidity | |retinal vein occlusion |
| Sentences | 118 |
| PubMedID- 21500185 | Results: nine eyes of 9 consecutive patients treated with a total of 9 sustained-release dexamethasone 0.7 mg intravitreal implants for macular edema associated with retinal vein occlusion were included. |
| PubMedID- 21337043 | Sham treatment in acute branch retinal vein occlusion with macular edema: results at 3 months (report 1). |
| PubMedID- 21866074 | Methods: the subjects were 44 branch retinal vein occlusion patients with macular edema and 16 controls. |
| PubMedID- 20653482 | Purpose: to evaluate secondary ocular hypertension after intravitreal injection of triamcinolone acetonide (ivta) with 2 mg/0.05 ml or 4 mg/0.1 ml for macular edema associated with retinal vein occlusion (rvo). |
| PubMedID- 21494891 | Introduction: the ozurdex((r)) (allergan inc., irvine, ca, usa) dexamethasone drug delivery system (dds) was recently developed as a biodegradable intravitreal implant to provide sustained delivery of 700 mug of preservativefree dexamethasone to the retina and vitreous, and is approved by the united states food and drug administration (fda) for the treatment of macular edema associated with retinal vein occlusion, as well as for noninfectious posterior uveitis. |
| PubMedID- 24330936 | There is an urgent requirement to find effective therapeutic procedures for the treatment of refractory eye diseases of posterior segment such as posterior uveitis, proliferative vitreoretinopathy, and macular edema associated with diabetes and retinal vein occlusion. |
| PubMedID- 20148661 | Intravitreal bevacizumab (avastin) in the treatment of macular edema associated with perfused retinal vein occlusion. |
| PubMedID- 22876931 | Background: the influence of serous retinal detachment (srd) on visual acuity, macular sensitivity, and macular thickness is unclear after intravitreal injection of triamcinolone acetonide (ivta) for macular edema with branch retinal vein occlusion (brvo). |
| PubMedID- 21538003 | Purpose: to investigate the correlation of soluble intercellular adhesion molecule 1 (sicam-1) and vascular endothelial growth factor (vegf) with macular edema in patients with central retinal vein occlusion (crvo). |
| PubMedID- 24531560 | Association of electroretinogram and morphological findings in central retinal vein occlusion with macular edema. |
| PubMedID- 23160823 | The objective of this study is to evaluate functional and morphological changes of the macula after pars plana vitrectomy (ppv) for macular edema with branch retinal vein occlusion (brvo). |
| PubMedID- 21386915 | Visual prognosis and vitreous molecules after vitrectomy for macular edema with branch retinal vein occlusion. |
| PubMedID- 21811207 | Three treatments for macular edema because of branch retinal vein occlusion: intravitreous bevacizumab or tissue plasminogen activator, and vitrectomy. |
| PubMedID- 26285577 | Conclusion: the possibility of an infrequent complication like macular hole should be considered for intravitreal ranibizumab for macular edema with branch retinal vein occlusion. |
| PubMedID- 22492175 | Methods: we studied the relationship between foveal sensitivity, obtained as the "foveal threshold" by use of humphrey perimetry, and best-corrected visual acuity, converted to the logarithm of the minimum angle of resolution (logmar), for 117 eyes with epiretinal membrane (erm), 197 eyes with retinal vein occlusion associated with macular edema (rvome), and 158 eyes with central serous chorioretinopathy (csc). |
| PubMedID- 25383828 | Results: initial ophthalmic examination showed bilateral central retinal vein occlusion with macular edema, including serous macular detachment in the left eye. |
| PubMedID- 22304619 | Functional-morphological changes after intravitreal injection of triamcinolone acetonide for macular edema with branch retinal vein occlusion. |
| PubMedID- 22925843 | Patients and methods: the present study represents a retrospective review of eight patients presenting with central retinal vein occlusion complicated by macular edema with central foveolar thickness greater than 350 mum by cirrus-oct, zeiss. |